Analysis Predicts Medical Disposables Market to Reach US$ 326.4 Billion by 2033

According to a recently published Future Market Insights report, the medical disposables market share is expected to rise at a compound annual growth rate (CAGR) of 7.1% from 2023 to 2033, with revenues projected at US$ 153.5 billion in 2022. The market is expected to reach US$ 326.4 billion by the end of 2033. Bandages & Wound Dressings was the industry with the highest revenue share in 2022. From 2023 to 2033, the industry is projected to rise at a compound annual growth rate (CAGR) of 6.8%.

The rising incidence of Hospital Acquired Infections, an increasing number of surgical procedures, and the growing prevalence of chronic diseases leading to longer hospital admission have been the key factors driving the market.

The subsequent spike in the number of chronic illness cases and a rise in the rate of hospitalizations has fuelled the field of emergency medical disposables growth. The expansion of the medical disposables market is being fuelled by an increase in the prevalence of hospital-acquired illnesses and disorders, as well as a greater focus on infection prevention. For example, the prevalence of healthcare-associated infection in high-income countries ranges from 3.5% to 12%, whereas it ranges from 5.7% to 19.1% in low and medium-income countries.

A growing geriatric population, an increase in the incidence of incontinence issues, mandatory guidelines that must be followed for patient safety at healthcare institutions, and an increase in demand for sophisticated healthcare facilities is driving the medical disposables market.

Unleash the extraordinary. Claim your sample for unmatched efficiency:
https://www.futuremarketinsights.com/reports/sample/rep-gb-2227

The market in North America is expected to reach a valuation of US$ 131 Billion by 2033 from US$ 61.7 Billion in 2022. In August 2000, the Food and Drug Administration (FDA) issued guidance concerning healthcare single-use items reprocessed by third parties or hospitals. In this guidance, FDA stated that hospitals or third-party reprocesses would be considered manufacturers and regulated in the exact same manner. A newly used single-use device still has to fulfill the criteria for device activation required by its flagship when it was originally manufactured. Such regulations have been creating a positive impact on the medical disposables market in the U.S. market in specific and the North American market in general.

Competitive Landscape

The key companies in the market are engaged in mergers, acquisitions and partnerships.

The key players in the market include 3M, Johnson & Johnson Services, Inc., Abbott, Becton, Dickinson & Company, Medtronic, B. Braun Melsungen AG, Bayer AG, Smith and Nephew, Medline Industries, Inc., and Cardinal Health.

Some of the recent developments of key Medical Disposables providers are as follows:

In April 2019, Smith & Nephew PLC purchased Osiris Therapeutics, Inc. with the goal of expanding its advanced wound management product range.
In May 2019, 3M announced the acquisition of Acelity Inc., with the goal of strengthening wound treatment products.

Market Segments Covered in Medical Disposables Industry Analysis

By Product Type: